Nurse Practitioner, Family · Saint George, UT
NPI
1093226938
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
640 E 700 S Ste 105
Saint George, UT, 84770
Phone (435) 688-7770
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
803 services
Medicare patients, 2024
566
Average age 76
Drug cost, 2024
$2.5M
2,696 prescriptions
Company payments, 2025
$2,594
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher G Lamb was code 99213 (office e&m - established), 447 times for 377 patients. In total Christopher G Lamb billed 803 services in 4 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 447 | 377 | $54.79 | $24K |
| 99214 Office E&M - Established | Office | 308 | 218 | $78.76 | $24K |
| 99204 Office E&M - New | Office | 26 | 26 | $96.95 | $2,521 |
| 99203 Office E&M - New | Office | 22 | 22 | $65.39 | $1,439 |
By year: 2022 $76K for 1,060 services; 2023 $61K for 903 services; 2024 $53K for 803 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher G Lamb prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 441 prescriptions and refills. In total Christopher G Lamb wrote 2,696 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 441 | 606 | 83 | $379K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 211 | 312 | 82 | $9,398 |
| Montelukast Sodium Generic | 161 | 396 | 45 | $1,849 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 158 | 245 | 38 | $152K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 152 | 198 | 27 | $93K |
| Spiriva Respimat Tiotropium Bromide | 126 | 233 | 39 | $117K |
| Azithromycin Generic | 96 | 121 | 55 | $905 |
| Prednisone Generic | 78 | 86 | 45 | $258 |
| Roflumilast Generic | 75 | 142 | 23 | $5,006 |
| Trazodone Hcl Generic | 72 | 146 | 19 | $827 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 66 | 132 | 17 | $59K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 57 | 100 | 18 | $11K |
| Incruse Ellipta Umeclidinium Bromide | 54 | 84 | Under 11 | $30K |
| Breo Ellipta Fluticasone/Vilanterol | 47 | 73 | 13 | $29K |
| Opsumit Macitentan | 45 | 45 | Under 11 | $567K |
Brand drugs: 1,575 claims; generic drugs: 1,121 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher G Lamb $2,594 ($2,594 in general payments such as food, travel and fees) from 16 companies. The largest payer was Inspire Medical Systems, Inc. with $1,381.
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. INSP | 6 | $1,381 |
| Actelion Pharmaceuticals US, Inc. JNJ | 12 | $275 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $150 |
| Merck Sharp & Dohme LLC MRK | 4 | $122 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $99.26 |
| Philips North America LLC PHG | 2 | $83.94 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $83.76 |
| Axsome Therapeutics, Inc. AXSM | 4 | $80.26 |
| Harmony Biosciences LLC HRMY | 2 | $75.77 |
| Verona Pharma, Inc. VRNA | 3 | $56.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.